Ruben Blachman-Braun

Dr. Ruben Blachman-Braun

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
DGDaniel C. Gonzalez
Daniel C. Gonzalez
JOJesse Ory
Jesse Ory
RBRuben Blachman-Braun
Ruben Blachman-Braun
SNSirpi Nackeeran
Sirpi Nackeeran
JBJordan C. Best
Jordan C. Best
Ranjith RamasamyRanjith Ramasamy
Ranjith Ramasamy
Gonzalez DC, et al. World J Mens Health. 2021 Apr;39:e19. https://doi.org/10.5534/wjmh.200195

1 November 2016 in The Korean Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
NPNonanzit Pérez-Hernández
Nonanzit Pérez-Hernández
GAGad Aptilon-Duque
Gad Aptilon-Duque
MNMaría Cristina Nostroza-Hernández
María Cristina Nostroza-Hernández
GVGilberto Vargas-Alarcón
Gilberto Vargas-Alarcón
JRJosé Manuel Rodríguez-Pérez
José Manuel Rodríguez-Pérez
RBRuben Blachman-Braun
Ruben Blachman-Braun
Vitamin D is a molecule that is actively involved in multiple metabolic pathways. It is mostly known for its implications related to calcium metabolism. It has also been determined that it actively participates in the cardiovascular system, influencing blood pressure, coronary artery disease and other vascular diseases, such as heart failure and atrial fibrillation. Furthermore, it has been established that this vitamin is extensively involved in the regulation of both the renin angiotensin aldosterone system and the immune system. In this review, we present the different vitamin D metabolic pathways associated with the cardiovascular pathophysiology, and we include studies in animal and human models, as well as some of the controversies found in the literature. This review also incorporates an overview of the implications in the molecular biology and public health fields.

15 November 2024 in World Journal of Urology
Verified
Journal Article
Open access
PDF file
JPJoao G. Porto
Joao G. Porto
ABAnsh M. Bhatia
Ansh M. Bhatia
ABAbhishek Bhat
Abhishek Bhat
MAMaria Camila Suarez Arbelaez
Maria Camila Suarez Arbelaez
RBRuben Blachman-Braun
Ruben Blachman-Braun
HSHemendra N. Shah
Hemendra N. Shah
Purpose: The goal of this systematic review is to assess the temporal changes in outcomes and complications of transurethral resection of the prostate (TURP) from 2000 to 2022. Methods: We conducted a systematic review and meta-analysis of 103 randomized clinical trials from PubMed on TURP, involving 8521 patients. Studies were grouped by years: 2000–2004, 2005–2009, 2010–2014, and 2015–2022. We assessed International Prostate Symptom Score (IPSS), Peak Flow (Qmax), Post-void residue of urine (PVR), and post-operative complications. Heterogeneity was ranked as low (I2 < 25%), moderate (I2 = 25–75%), or high (I2 > 75%). Results: TURP significantly improved IPSS, Qmax, and PVR, with the most recent studies showing superior results in IPSS and Qmax after 3 years compared to 2000–2004 studies. Heterogeneity in PVR was high (I2 = 100%). No negative impact on erectile function was observed. Complication rates included TURP syndrome (2%), bleeding (8%), and blood transfusion (6%), but elevated heterogeneity with difference between the groups was seen in clot evacuation (I2 = 83%) and urinary tract infections (I2 = 82%). Other complications were urinary retention (4%), incontinence (8%), urethral stricture (3%), bladder neck stenosis (2%). Conclusion: In the last 20 years there has not been a clear trend in the results of TURP. The found heterogeneity may indicate a lack of standardization in TURP procedures. However, symptomatic improvement among patients is uniform, which supports this procedure as a historical benchmark surgical treatment for BPH.

1 May 2014 in Respiratory Medicine
Verified
Journal Article
Closed access
RBRuben Blachman-Braun
Ruben Blachman-Braun
RMRaquel Lira Del Mazo-Rodríguez
Raquel Lira Del Mazo-Rodríguez
GLGustavo López-Sámano
Gustavo López-Sámano
Ivette Buendia-RoldanIvette Buendia-Roldan
Ivette Buendia-Roldan

1 September 2020 in Journal of Urology
Verified
Journal Article
Closed access
TLThiago Fernandes Negris Lima
Thiago Fernandes Negris Lima
PPPremal Patel
Premal Patel
RBRuben Blachman-Braun
Ruben Blachman-Braun
VMVinayak Madhusoodanan
Vinayak Madhusoodanan
Ranjith RamasamyRanjith Ramasamy
Ranjith Ramasamy
Introduction and Objective:Intratesticular testosterone (ITT) is essential for spermatogenesis and can only be reliably measured with invasive testicular sampling. Previous studies have demonstrate...